BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$9.43
+7.77%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- -$32
- Revenue estimate
- $1.9M
Latest reported
- Last report date
- Aug 7, 2026
- EPS actual
- -$0.64
- EPS estimate
- -$2.10
- Revenue actual
- $1.5M
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +48.7%
- Revenue beats (12Q)
- 3
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 7, 2026 | -$2.10 | -$0.64 | Beat 69.52% | $1.5M |
| May 8, 2026 | -$2.40 | -$0.81 | Beat 66.25% | $1.4M |
| Mar 13, 2026 | -$2.70 | -$1.11 | Beat 58.89% | $1.6M |
| Nov 14, 2025 | -$2.70 | -$2.70 | In line | $1.4M |
| Aug 14, 2025 | -$2.70 | -$3.90 | Miss -44.44% | $1.3M |
| May 15, 2025 | -$0.16 | -$0.16 | In line | $1.9M |
| Mar 31, 2025 | -$0.14 | -$0.21 | Miss -50.00% | $2.2M |
| Nov 14, 2024 | -$0.15 | -$0.16 | Miss -6.67% | $2.4M |
| Aug 14, 2024 | -$0.17 | -$0.19 | Miss -11.76% | $2.4M |
| May 15, 2024 | -$0.15 | -$0.21 | Miss -40.00% | $2.4M |
| Nov 14, 2023 | -$0.18 | -$0.26 | Miss -44.44% | $298.5K |
| Aug 14, 2023 | -$0.13 | -$0.20 | Miss -53.85% | $19.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026